Task: Answer the MCQ question.
Query: Which compound exhibits a 18.708\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a C[N+]1(CC(=O)Nc2ccc(F)cc2)CCN(C(=O)c2ccco2)CC1.[Cl-]
b Cc1cccc(-c2noc(CN(C(=O)c3ccc4c(c3)OCO4)C(C)C)n2)c1
c Cc1cccc(NC(=O)CCNS(=O)(=O)c2cccc3nsnc23)c1
d CCCCCCNC(=O)c1cn(CC)c2cc(N3CCN(C)CC3)c(F)cc2c1=O
Answer: c. Cc1cccc(NC(=O)CCNS(=O)(=O)c2cccc3nsnc23)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
3-(2,1,3-benzothiadiazol-4-ylsulfonylamino)-N-(3-methylphenyl)propanamide